Consultant Physician in Medical Oncology at University Hospital of Toledo, Toledo, Spain
Spain
Dr. Mauro Javier Oruezábal Moreno is a respected Consultant Medical Oncologist, Hematologist, and Cancer Genetic Counselor with vast expertise in Medical Oncology, Genetic Counseling in Cancer, and research. Based in the University Hospital of Toledo, Spain, he is actively involved in clinical trials for breast, lung, colorectal, urological tumors, and ovarian cancers. Dr. Oruezábal Moreno has received recognition for his contributions, including the II MAFID Awards, and has a strong commitment to advancing cancer care and research excellence.
Dr. Mauro Javier Oruezábal Moreno is a distinguished Consultant Medical Oncologist, Hematologist and Cancer Genetic Counselor with extensive experience and expertise in the field. Currently serving at the University Hospital of Toledo, Spain, he has held key positions in both clinical practice and academia at reputable institutions, including the Rey Juan Carlos University Hospital in Madrid, Spain.
In addition to his clinical roles, Dr. Oruezábal Moreno is actively involved in research and academia. He has conducted significant research in areas such as the evaluation of chemotherapy response using Positron Emission Tomography (PET) and the management of cancer pain. Furthermore, his expertise extends to bioinformatics and biostatistics, as well as genetic analysis related to cancer pathogenicity research.
Dr. Oruezábal Moreno has showcased his leadership by directing the Master's Degree in Oncology at CEU Cardenal Cisneros University and engaging in various clinical trials related to breast, lung, and ovarian cancers. His participation in these trials reflects his dedication to advancing knowledge in oncology and exploring innovative treatment options.
Recognized for his contributions to the field, Dr. Oruezábal Moreno has received several awards and honors, including the II MAFID Awards for his significant contributions to training, research, and teaching in the medical community. His fellowship at the Genetic Department and Cancer Research UK at Southampton University Hospital underscores his commitment to excellence in cancer research and patient care.
CEU Cardenal Cisneros University, Spain
University Hospital of Toledo, Toledo, Spain
Pivotal CRO
Rey Juan Carlos University, Spain.
The Rey Juan Carlos University Hospital, Madrid, Spain
Cancer Research, Southampton University, UK
University Hospital of Parla, Madrid, Spain
General Hospital of Alcázar de San Juan, Ciudad Real, Spain
The Open University of Catalonia
2018
College of Physicians and Surgeons of Spain
2016
Pablo Olavide University of Seville
2015
UPF Barcelona School
2015
2004
Universidad Complutense de Madrid
2002
College of Physicians and Surgeons of Spain
2000
University of Navarra
1994